Physician profile
Anna Sanders
NPI 1952054454
$571.75
in general payments reported to CMS, 2019-2025
13 companies · $36.80 in 2025
The $36.80 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $403 · 2024: $132 · 2025: $36.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $143.41 | 2023-2024 | |
| Corium, LLC | $98.53 | 2023 | Azstarys |
| Novo Nordisk INC | $92.72 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Ironshore Pharmaceuticals INC. | $35.91 | 2023 | Jornay Pm |
| Tris Pharma INC | $33.65 | 2023 | Dyanavel Xr |
| Astellas Pharma US INC | $32.78 | 2023-2024 | Myrbetriq, Veozah |
| Lundbeck LLC | $31.23 | 2023 | Vyepti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.87 | 2025 | |
| Inspire Medical Systems, INC. | $19.43 | 2024 | Inspire |
| Ironwood Pharmaceuticals, INC | $16.82 | 2024 | |
| Idorsia Pharmaceuticals US INC | $16.11 | 2023 | Quviviq |
| Pfizer INC. | $15.13 | 2023 | |
| Exact Sciences Corporation | $13.16 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.